This is a two-part series looking at how modern genomics is changing clinical practice, and how a physician can hope to keep up with the pace of discovery and technological development. Part 2 begins with the question of disease risk and how to present uncertain predictive diagnoses. This is particularly relevant to research using genome-wide association studies, which is finding more and more markers with small risks of disease. The ethics of consenting patients to genome screening and informing them of potential markers are discussed, as well as gene-targeted treatments at the cutting edge of cancer research.
Guests: Associate Professor Kristine Barlowe-Stewart FHGSA(GenCounsel) (Director, Master of Genetic Counselling Program, University of Sydney), Professor Leslie Burnett FRCPA, FHGSA, FCAP (Chief Medical Officer, Genome One), Dr Michael Gabbett FRACP (Royal Brisbane and Women’s Hospital), Dr David Thomas FRACP (Director, Kinghorn Cancer Centre; Director, Cancer Division, Garvan Institute for Medical Research).
Links to resources mentioned on the show are provided on the RACP website.
Create your
podcast in
minutes
It is Free